pycnogenols: Clinical Trials

2 trials of pycnogenols, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow pycnogenols: new trials by email Literature Review of pycnogenols trials Research Report on pycnogenols

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pycnogenol® in Post-COVID-19 Condition
Pycnogenol®, Placebo - Post COVID-19 Condition, Long COVID
Phase 3CompletedUniversity of Zurich1532023-06-072026-04-29
Effect of Pycnogenol® on ADHD
Pycnogenol, Methylphenidate, Placebo - ADHD
Phase 3CompletedNina Hermans882017-09-012021-04-28

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  COVID-19 (1)  ·  Post-Acute COVID-19 Syndrome (1)

Sponsors

Nina Hermans (1)  ·  University of Zurich (1)

Countries

Belgium (1)  ·  Switzerland (1)

Top investigators

Alexia Anagnostopoulos, MD (1)  ·  Jahn S Fehr, Prof., MD (1)  ·  Nina Hermans, PhD (1)

Results publications

PMID 28351412, PMID 38879571, PMID 42118816, PMID 42790915